FDA extended the age indication for PCV13 (Prevnar 13) to include adults age 18 through 49 years
On Jul. 12, 2016, Pfizer announced that Prevnar 13ᆴ (Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein]) received FDA…
On Jul. 12, 2016, Pfizer announced that Prevnar 13ᆴ (Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein]) received FDA…
On Sept. 4, 2015, the U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices…
On Sept. 19, 2014, the Centers for Disease Control and Prevention”s (CDC) Advisory Committee on Immunization Practices (ACIP)…
On Jun. 28, 2013, the Advisory Committee on Immunization Practices (ACIP) recommended routine use of 13-valent pneumococcal conjugate…
On Jan. 25, 2013, Pfizer announced the FDA had granted approval for the expansion of the companyメs pneumococcal…
On Dec. 30, 2011, Pfizer announced that the U.S. Food and Drug Administration (FDA) had granted approval of…
On Feb. 24, 2010, a 13-valent pneumococcal conjugate vaccine (PCV13 [Prevnar 13, Wyeth Pharmaceuticals, a subsidiary of Pfizer])…
On Nov. 16, 2009, the U.S. Centers for Disease Control and Prevention (CDC) recommended a single dose of…
On Nov. 12, 2009, the Global Coalition against Child Pneumonia was established to raise awareness about the toll…
On Oct. 7, 2005, a new Federal Medicare rule became effective that required all long-term care facilities to…
On Mar. 6, 2003, the Singapore Ministry of Health (MOH) and the World Health Organization (WHO), announced they…
On April 4, 1997, the Immunization Practices Advisory Committee (ACIP) recommended that the vaccine be used more extensively…
In 1989, recommendations for routine 2nd doses of measles-containing vaccine were issued by both ACIP and the American…
In 1986, Dr. Marilyn Hughes Gaston while deputy branch chief of the Sickle Cell Disease Branch at the…
On Jun. 30, 1983, the U.S. Food and Drug Administration (FDA) licensed two enhanced pneumococcal polysaccharide vaccines (Pneumovax…
On Jul. 1, 1981, as a result of the enactment of Public Law 96-611 passed by the U.S….
On Jun. 5, 1981, Pneumocystis Pneumonia, Los Angeles, by Dr. Michael Gottlieb and colleagues of University of California…
In 1981, the U.S. Centers for Disease Control and Prevention (CDC) began collecting reports of influenza outbreaks from…
In 1978, the U.S. Centers for Disease Control and Prevention (CDC) held its first international conference on Legionnaires’…
On Nov. 21, 1977, the U.S. Food and Drug Administration (FDA) licensed the first pneumococcal vaccine containing 14…
In 1977, the U.S. Centers for Disease Control and Prevention (CDC) isolated Legionella pneumophila, which caused a deadly…
In 1976, Influenza A/Victoria-like strains had been identified in New Jersey as early as January 21. The novel…
In 1962, the U.S. Centers for Disease Control and Prevention (CDC) launched the 122 Cities Mortality Reporting System…
In 1949, Walter Hagemeyer Burkholder, a pioneer in bacterial taxonomy, described the bacteria, Pseudomonas cepacia, now known as…
In 1942, “Louisiana pneumonitis,” a human disease possibly related to psittacosis, was discovered and studied in great detail…
On Apr. 1, 1919, the Stanley Cup playoffs between the Montreal Canadians and the Seattle Metropolitans ended tied…
On Dec. 23, 1918, the Cincinnati Board of Health removed its ban prohibiting children from entering public places….
On Dec. 6, 1918, Salt Lake City and Utah health officials met to modify their closure order, to…
By Nov. 16, 1918, Chicago had experienced a total of 38,000 cases of influenza and 13,000 cases of…
By Nov. 16, 1918, the New York influenza figures overall, from September 15 through November 16 – the…